Pharma Stocks Lift Sensex, Nifty As Dr Reddy’s Hits Record High
The pharmaceutical firm hit an all-time high and was the top boost to the Nifty 50 as it settled a patent litigation with Bristol-Myers Squibb Co over the cancer treatment Revlimid.
Keep The Best In Your Boundary
